SPDR S&P 500 (SPY)

[Dr Jerry]

2 companies with promising therapeutics

IPIX with a broad spectrum antiviral lower COVID load by 97% in lung tissue (excellent prospect)

CYDY has CCD5 antagonist that blocks cytochemic receptors on the host cells

both have very strong science behind them, first one has been in over 8 human trials with no severe adverse affects and met all endpoints 8 times.

Vaccines won't work

SPY could breakout if one or both of these agents were successful

C wave is lingering in the background assuming COVID is not stoppable